Stockwinners Market Radar for August 26, 2018 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
TSLA... | Hot Stocks19:29 EDT On The Fly: Top five weekend stock stories - Catch up on the weekend's top five stories with this list compiled by The Fly: 1. Tesla (TSLA) CEO Elon Musk has announced in a blog post that his company will remain public. The post reads in part, "Given the feedback I've received, it's apparent that most of Tesla's existing shareholders believe we are better off as a public company...I knew the process of going private would be challenging, but it's clear that it would be even more time-consuming and distracting than initially anticipated...After considering all of these factors, I met with Tesla's Board of Directors yesterday and let them know that I believe the better path is for Tesla to remain public. The Board indicated that they agree." 2. In a tweet over the weekend, President Donald Trump said: "Our relationship with Mexico is getting closer by the hour. Some really good people within both the new and old government, and all working closely together....A big Trade Agreement with Mexico could be happening soon!" Meanwhile, citing Mexican Economy Minister Ildefonso Guajardo, Reuters reported that U.S. and Mexican trade negotiators may be "hours" away from squaring away bilateral differences on the North American Free Trade Agreement but work with Canada is likely to stretch into September. 3. The cloud is the future of videogaming, and it could arrive sooner than many players expect, Jack Hough wrote in this week's edition of Barron's. Once pricey hardware is no longer necessary and top-tier games can run on two-year-old smartphones, even casual gamers will become candidates for the latest releases from Electronic Arts (EA), he added. But just as streaming could turbocharge growth for game makers like EA and Activision Blizzard (ATVI), it could also present challenges for hardware players like Nvidia (NVDA), Microsoft (MSFT) and Sony (SNE), the report noted. 4. AT&T (T) subsidiary Warner Bros' "Crazy Rich Asians" led the weekend's box office again with $25M in its second outing, almost as much as the movie earned in its debut. "Crazy Rich Asians" earned an A CinemaScore and sports a 92% Rotten Tomatoes score. 5. GlaxoSmithKline (GSK) and Tencent (TCEHY) saw positive mentions in Barron's, while L Brands (LB) was mentioned cautiously.
|
BGNE | Hot Stocks18:11 EDT BeiGene announces first NDA for Zanubrutinib by China Drug Administration - BeiGene has announced the acceptance by the China Drug Administration of a new drug application for zanubrutinib, an investigational Bruton's tyrosine kinase inhibitor, for the treatment of patients with relapsed/refractory mantle cell lymphoma. Zanubrutinib was discovered in BeiGene's research facilities in Beijing, China, and is being developed globally by BeiGene as a monotherapy and in combination with other therapies to treat various hematologic malignancies. The NDA is supported by an extensive clinical and non-clinical data package, including the results from an 86-patient single-arm pivotal Phase 2 study in Chinese patients with relapsed or refractory MCL treated with zanubrutinib, dosed at 160 mg orally twice daily. An independent review of response data from this study showed overall response rate of 84%, including 59% of patients who achieved a complete response. With 8.3 months median follow-up, the median duration of response has not been reached, as a majority of the responders remain in a response. The safety profile was consistent with previously reported clinical data for zanubrutinib. Full results of the study are planned to be presented at an upcoming medical conference. Zanubrutinib is being studied in several clinical trials as part of a broad development program and was recently granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of patients with Waldenstrom macroglobulinemia. BeiGene plans to submit an NDA to the FDA for zanubrutinib as a potential treatment for patients with WM in the first half of 2019 based on results from a global Phase 1 study. In addition to the global Phase 1 trial of zanubrutinib, it is also being evaluated in a fully-enrolled, global Phase 3 clinical trial in patients with WM comparing zanubrutinib to ibrutinib, the currently approved BTK inhibitor for WM. Zanubrutinib is also being studied in a global Phase 3 clinical trial in patients with previously untreated chronic lymphocytic leukemia and a pivotal Phase 2 trial in patients with relapsed/refractory follicular lymphoma in combination with GAZYVA.
|
T... | Hot Stocks16:56 EDT Box Office Battle: 'Crazy Rich Asians' retains top spot with $25M - AT&T (T) subsidiary Warner Bros' "Crazy Rich Asians" led this weekend's box office again with $25M in its second outing, almost as much as the movie earned in its debut. "Crazy Rich Asians" earned an A CinemaScore and sports a 92% Rotten Tomatoes score. BOX OFFICE RUNNERS-UP: "The Meg," another Warner Bros. movie, stayed at number two in its third weekend, grossing an estimated $13M from 4,031 theaters. Behind it was STX Entertainment's "The Happytime Murders," ending its debut weekend with $10M domestically from 3,526 theaters in a career low for Melissa McCarthy. Viacom (VIAB) owned Paramount's "Mission: Impossible - Fallout" placed number four, with $8M from 3,052 locations. Rounding out the top five, Disney's (DIS) "Christopher Robin" grossed an estimated $6.3M from 3,395 locations. Other publicly traded companies in filmmaking include 21st Century Fox (FOXA), Lionsgate's (LGF.A), Comcast (CMCSA; CMCSK), and Sony (SNE).
|
SPY SPX | Hot Stocks13:29 EDT President Trump says Mexico trade deal near - In a tweet, President Donald Trump said: "Our relationship with Mexico is getting closer by the hour. Some really good people within both the new and old government, and all working closely together....A big Trade Agreement with Mexico could be happening soon!" Reference Link
|
AMRN | Hot Stocks13:00 EDT Amarin's REDUCE-IT study on-track to report results before end of September - Amarin commented that following this week's European Society of Cardiology Congress in Munich, Germany, its landmark cardiovascular outcomes study, REDUCE-IT, is now likely to be the next large cardiovascular outcomes study to report results. As previously guided, top-line results from the REDUCE-IT study are expected to be reported before the end of September 2018. REDUCE-IT is evaluating the effect of Vascepa, administered at four grams per day, as an add-on to statin therapy, on major adverse cardiovascular events as compared to statin treated patients plus placebo. REDUCE-IT is the first cardiovascular outcomes study to be conducted in patients who despite low density lipoprotein cholesterol control have risk factors for cardiovascular disease, including elevated triglyceride levels. The company said that its REDUCE-IT study of Vascepa is noticeably different than the recently completed ASCEND trial presented today at ESC 2018. ASCEND studied a different drug in a different patient population.
|
AMD | Hot Stocks12:55 EDT AMD announces new Radeon Pro V340 graphics card - AMD has announced the Radeon Pro V340 graphics card, a high-performance dual-GPU Virtual Desktop Infrastructure solution purpose-built to power and accelerate the most demanding datacenter visualization workloads, including CAD, design, Desktop as a Service and rendering. The AMD Radeon Pro V340 graphics card is a dual-GPU solution based on the advanced AMD "Vega" architecture1, optimized to deliver extreme performance and high user density for virtualized environments. It is the first VDI hardware solution equipped with 32GB of ultra-fast, second-generation high-bandwidth memory, providing massive amounts of memory and bandwidth for today's most complex design and media workloads. The AMD Radeon Pro V340 graphics card is enabled by AMD MxGPU Technology, the industry's only hardware-based GPU virtualization solution, which is based on the industry-standard SR-IOV technology. Combining software and hardware technologies that deliver virtualized graphics for the modern cloud, AMD MxGPU delivers fast, stable and predictable performance with the industry's highest user density2, without requiring recurring end-user license fees. The AMD Radeon Pro V340 graphics card is expected to be available in Q4 2018 from leading system providers.
|
TAHO | Hot Stocks12:52 EDT Tahoe Resources announces kidnapping of 12 security contractors in Guatemala - Tahoe Resources regrets to announce that twelve of Minera San Rafael's unarmed security contract workers were attacked and kidnapped late in the evening of August 24. The private contractors were unarmed and remained peaceful during the entire period. After several hours of being abducted, injured and held at gun point, the contractors were eventually released and escorted by the Guatemalan Civil National Police back to Jalapa where they were treated for their injuries and trauma.
|